Investors

Press Releases

 
Press Releases
  Date Title View
Mar 27, 2008
Research Triangle Park, N.C., March 27, 2008 – SCYNEXIS, Inc. a premier drug discovery and development company, today announced the successful completion of a $13.5 million Series C-2 financing. The financing was led by Merial Limited, a joint venture between Merck & Co., Inc. and sanofi-aventis. SR One, GlaxoSmithKl...
FirstPrevious ...
13
= add release to Briefcase